Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation
- 31 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 3 (1), 37-44
- https://doi.org/10.1016/j.jcf.2003.12.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosaThe Lancet, 2001
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- Antibiotic treatment of initial colonization withPseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosisPediatric Pulmonology, 1997
- Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinicThe Lancet, 1996
- Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for TransplantationClinical Infectious Diseases, 1996
- Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosaThe Netherlands Journal of Medicine, 1995
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993
- Pseudomonas aeruginosacross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probeEpidemiology and Infection, 1989
- Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infectionJournal of Antimicrobial Chemotherapy, 1987